The increase rate of diabetes patients is higher in men than in women.

Panoramic view of the main building of the Health Insurance Review and Assessment Service

(Health Korea News / Chang-yong Lee) Over the past five years, the rate of increase in diabetes patients has been found to be higher in men than in women.

On the 14th, the Health Insurance Review and Assessment Service (HIRA) announced the results of a survey on the status of diabetes care over the past five years (2019-2023) in celebration of ‘World Diabetes Day’.

According to the survey results, the number of male patients increased by 19.6% (annual average of 4.6%) over 5 years from 1,794,777 in 2019 to 2,146,381 in 2023. During the same period, total medical expenses increased by 30.1% (average annual rate of 6.8%) from KRW 505.3 billion to KRW 657.2 billion.

During the same period, the number of female patients increased by 17.3% (average annual rate of 4.1%) from 1,433,783 to 1,682,301, and total medical expenses increased by 20.6% (average annual rate of 4.8%) from KRW 430.4 billion to KRW 519.3 billion.

Diabetes treatment status by gender over the past 5 years (2019-2023) (unit: people, KRW 100 million, KRW, %)
Status of diabetes treatment by gender for the past 5 years (2019-2023) (Unit: people, KRW 100 million, KRW, %) (Table = Provided by Review and Assessment Service)

Looking at the trends in diabetes care by inpatient and outpatient clinic over the past five years (2019-2023), the number of hospitalization claims decreased by 12.5% ​​(average annual average of 3.3%), and the number of outpatient claims increased by 9.6% (average annual average of 2.3%).

The number of hospitalized patients decreased by 6.1% (average annual rate of 1.6%) over the past five years from 94,248 in 2019 to 88,465 in 2023, while total annual medical expenses during the same period decreased by 3.0% (average annual rate of 0.7%) from KRW 283.8 billion to KRW 292.4 billion. ) increased. Medical expenses per case also increased from 1,677,344 won to 1,975,510 won.

The number of outpatients increased by 18.7% (average annual rate of 4.4%) from 3,210,072 in 2019 to 3,810,377 in 2023, and total annual medical expenses also increased by 35.6% (average annual rate of 7.9%) from KRW 651.9 billion to KRW 884.1 billion. Medical expenses per case also increased from 28,658 won to 35,451 won.

Diabetes treatment status by inpatient and outpatient for the past 5 years (2019-2023) (unit: people, KRW 100 million, KRW, %) (Table = provided by Review and Assessment Service)

Looking at the number of patients receiving treatment compared to the population by age group over the past five years, it was found that more than 15 out of 100 people in their 60s or older received treatment for diabetes, and the ratio of patients in the age group under 20s was found to be increasing significantly. Done.

Among the age groups that received the most diabetes treatment in 2023, those in their 70s were the largest at 21.79% (864,383 people), followed by those in their 80s or older at 18.46% (434,449 people), and those in their 60s at 16.40% (1,251,421 people). .

Diabetes treatment status by age for the past 5 years (2019-2023) (unit: people, %) (Table = Provided by Review and Assessment Service)

Over the past five years, the number of diabetes patients accompanied by high blood pressure disease has increased by 23.1% (annual average of 5.3%) from 1,499,308 in 2019 to 1,845,265 in 2023.

During the same period, total annual medical expenses increased by 24.5% (annual average 5.6%) from KRW 440.7 billion to KRW 548.7 billion, and medical expenses per person also increased from KRW 293,938 to KRW 297,355.

During the same period, the number of patients with diabetes accompanied by cardiovascular disease increased by 14.8% (annual average of 3.5%) from 223,647 to 256,801, and total medical expenses increased by 24.1% (annual average of 5.5%) from KRW 88 billion to KRW 109.1 billion. Medical expenses per person increased from 393,279 billion won to 424,935 people. appeared to be increasing.

Current status of simultaneous claims for high blood pressure and cardiovascular disease over the past 5 years (2019-2023) (Unit: people, KRW 100 million, KRW, %) (Table = Provided by Review and Assessment Service)

Looking at the frequent comorbidities of diabetes in 2023, lipoprotein metabolism disorders and other lipidosis accounted for the largest proportion at 39.8% (1,524,737 people), essential hypertension 33.7% (1,294,737 people), and liver disease. Other diseases came in at 3.0% (113,707 people).

Status of treatment for top 5 diabetes common diseases (unit: people, %) (Table = Provided by Review and Assessment Service)

Jeong Jae-heung, head of Big Data at HIRA, said, “If you look at the status of diabetes treatment over the past five years, most patients are over 40 years old, but the proportion of patients under 20 is increasing, so we need to detect diabetes early through regular checkups in all age groups. “I hope we can manage it,” he said.

Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited

Source: www.hkn24.com